• Review lipoprotein metabolism and disorders, including recent data on the prevalence of familial hypercholesterolemia (FH).

  • Characterize mechanisms of action of standard cholesterol-lowering therapy and efficacy in FH.

  • Describe “experiments” of nature which have led to new therapeutic agents. 

Review the clinical efficacy of these novel drugs, including expert consensus on their use






Charlotte Boney M.D.
 Professor and Chair, Dept Pediatrics
University of Massachusetts Medical School-Baystate
Baystate Children's Hospital

Session date: 
01/30/2018 - 12:00pm to 1:00pm EST
Baystate Medical Center
759 Chestnut St
Springfield, MA 01199
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC Contact Hours
  • 1.00 BCIPE Instructional Hours

Please login or register to take this course.